ASX Share rice
Mon 17 May 2021 - 10:24:am (Sydney)

S66 Share Price

STAR COMBO PHARMA LIMITEDS66Household & Personal Products

S66 Company Information

Name:

Star Combo Pharma Limited

Sector:

Consumer Defensive

Industry:

Household & Personal Products

GIC Industry:

Personal Products

GIC Sub Industry:

Personal Products

Address:

171-177 Woodpark Road Smithfield NSW Australia 2164

Phone:

61 2 9756 6555

CEO & Exec. Director:

Ms. Su Zhang M.B.A.

Founder, MD & Director:

Mr. JinXing Zhang B.S.

Chief Financial Officer:

Mr. Daniel Zheng C.A., M.B.A.

Chief Operating Officer:

Mr. He Ben B.S.

Group Accountant:

James Ni

Company Sec.:

Mr. Patrick James Raper F.A.C.I.D., FAICD, FCPA

Company Overview:

Star Combo Pharma Limited engages in the manufacture and distribution of health food products and nutritional supplements in Australia and China. The company operated in two segments, Star Combo and Austoyou Retail. It develops, manufactures, markets, and sells natural health supplements and skin care products. The company also provides its products through e-commerce platform to Chinese health product consumers; and two retail stores in Sydney. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.

S66 Share Price Information

Shares Issued:

134.71M

Market Capitalisation:

$33.68M

Revenue (TTM):

$32.61M

Revenue Per Share (TTM):

$0.34

Earnings per Share:

$0.015

Profit Margin:

0.0434

Operating Margin (TTM):

$-0.02

Return On Assets (TTM):

$-0.01

Return On Equity (TTM):

$0.04

Quarterly Revenue Growth (YOY):

-0.306

Gross Profit(TTM):

$4.06M

Diluted Earnings Per Share (TTM):

$0.015

S66 CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-3,627,056

Change To Liabilities:

$-620,648

Total Cashflow From Investing Activities:

$-3,627,056

Net Borrowings:

$1.64M

Net Income:

$-348,688

Total Cash From Operating Activities:

$-1,018,164

Depreciation:

$714.85K

Other Cashflow From Investing Activities:

$-250,000

Change To Inventory:

$-441,507

Change To Account Receivables:

$251.78K

Sale Purchase Of Stock:

$33.32M

Capital Expenditures:

$2.72M

S66 Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-906,410

Net Income:

$-348,690

Gross Profit:

$4.06M

Operating Income:

$-1,710,990

Interest Expense:

$393.87K

Income Tax Expense:

$-557,725

Total Revenue:

$39.08M

Cost Of Revenue:

$35.03M

S66 Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$2.89M

Total Liabilities:

$10.22M

Total Stockholder Equity:

$44.50M

Other Current Liabilities:

$1.97M

Total Assets:

$54.72M

Common Stock:

$67.74M

Other Current Assets:

$241.42K

Retained Earnings:

$1.23M

Other Liabilities:

$604.63K

Good Will:

$6.34M

Other Assets:

$1.46M

Cash:

$26.60M

Total Current Liabilities:

$4.66M

Property - Plant & Equipment:

$8.69M

Net Tangible Assets:

$35.27M

Total Current Assets:

$35.34M

Long-Term Debt:

$1.49M

Net Receivables:

$3.12M

Short-Term Investments:

$19.38M

Inventory:

$5.38M

Accounts Payable:

$2.03M

Short-Term Investments:

$19.38

Non Current Liabilities Total:

$5.55M

S66 Share Price History

S66 News

10 Nov, 2020
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...